Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Insider Information: Reima Rytsölä has been appointed President and CEO of Kojamo

Kojamo plc Insider Information, 28 November 2024 at 8:30 a.m. EETInsider Information: Reima Rytsölä has been appointed President and CEO of Kojamo The Board of Directors of Kojamo plc has appointed Reima Rytsölä (M.Soc.Sc.) President and CEO of Kojamo plc. He will start in his position latest on 1 June 2025. Erik Hjelt will continue as interim CEO until Reima Rytsölä assumes his role. Reima Rytsölä has significant experience and a strong track record in his career in the financial and investment sectors, including real estate investment. He joins Kojamo from the position of CEO in

Halton Group announces changes to its business area structure and Senior Executive Team

Halton is renewing its strategic business area structure to strengthen its application-specific competitiveness and customer focus. The current SBA Halton Business Area will be restructured into two new business areas: Halton Buildings and Halton Health and Cleanroom. Meanwhile, the structures of Halton Foodservice and Halton Marine, Energy, and Infrastructure will remain unchanged.“The target is to operate even more closely with our customers. The two new units will help sharpen our focus on specific application areas, accelerate implementations, and act more agilely in new markets,” says

Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate [177]Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data highlights the strong therapeutic potential of [177]Lu-AKIR001, with first patient enrollment anticipated in early 2025. The presentation will be delivered by Dr. Marika Nestor, CEO of Akiram Therapeutics and Professor of Biomedical Radiation Sciences at Uppsala

CapMan Plc Managers' Transactions – Frimodig

CapMan PlcStock Exchange Release / Managers’ Transactions           28 November 2024 at 8 a.m. EET CapMan Plc Managers' Transactions – Frimodig CapMan Plc has received the following notification under Article 19 of the Market Abuse Regulation from Frimodig, Joakim. ____________________________________________ Person subject to the notification requirement Name: Joakim Frimodig Position: Member of the Board/Deputy member Issuer: CapMan Oyj LEI: 743700498L5THNQWVL66 Notification type: INITIAL NOTIFICATION Reference number: 86289/5/4 ________________________

CapMan Plc Managers' Transactions – Frimodig

CapMan PlcStock Exchange Release / Managers’ Transactions            28 November 2024 at 8 a.m. EET CapMan Plc Managers' Transactions – Frimodig CapMan Plc has received the following notification under Article 19 of the Market Abuse Regulation from Frimodig, Joakim. ____________________________________________ Person subject to the notification requirement Name: Joakim Frimodig Position: Member of the Board/Deputy member Issuer: CapMan Oyj LEI: 743700498L5THNQWVL66 Notification type: INITIAL NOTIFICATION Reference number: 86284/5/4 _______________________

Skanska carries out site preparation for upcoming neighborhood in Stockholm, Sweden, for about SEK 300M

Skanska has signed a contract with the Exploitation Office of the City of Stockholm to carry out site preparation for an upcoming neighborhood at Årstafältet, south of Stockholm, Sweden. The contract is worth about SEK 300M which will be included in the order bookings for Skanska Sweden for the fourth quarter of 2024.The contract includes ground- and utility works with elements of landscaping. The work mainly involves soil reinforcement, extensive and complex new installations and relocations of utilities, as well as the construction of service roads. The project will use 100% fossil-

Summa Defence to Establish a Drone Production Facility in Finland with Ukrainian Partners

Summa Defence Ltd                                                                              Press release, free for publication on 28.11.2024 at 8:00 EET  The Finnish defense and security technology group Summa Defence Ltd is establishing a drone production facility in Finland in collaboration with its Ukrainian partners. The purpose of the facility is to rapidly increase production capacity for drones used in combat in Ukraine, while also introducing industrial-scale drone production in Finland and Europe. Widescale drone production is planned to begin in the first half of

Cavendish Hydrogen ASA: Third Quarter 2024 Financial Results

(November 28[th], 2024 – Oslo, Norway) Cavendish Hydrogen ASA (Cavendish, OSE:CAVEN) reported revenues in the third quarter of EUR 5.7 million, a 19 % decline from the prior-year period due to fewer equipment deliveries.The EBITDA result was EUR -4.1 million, representing an improvement from EUR -4.8 million in the corresponding period of 2023, despite lower revenues. The EBITDA improvement was driven by improved gross margins combined with disciplined cost management. Quarterly highlights: · Fewer equipment deliveries resulted in a 19 % revenue decline. · Strong progress in

Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024

Third quarter: 1 July – 30 September June 2024  · Net revenue increased by 11,7 % to 308 858 (276 583) TSEK · Organic growth amounted to 1,7 % (-13,5 %) · Gross margin amounted to 28,8 % (29,4 %) · Adjusted EBITA amounted to 28 049 (22 460) TSEK · Operating profit amounted to 26 018 (20 876) TSEK · Net income amounted to 19 013 (15 265) TSEK · Earnings per share, before and after dilution, amounted to 1,56 (1,25) SEK · Cash flow from operations amounted to 24 999 (66 631) TSEK · Cash and cash equivalents amounted to 198 192 (221 956) TSEK · Net debt in

Why Homeowners Are Choosing Improving Over Moving

The traditional dream of moving to achieve your dream home goals has lost its lustre in recent years. Instead, many homeowners are now opting to invest in their existing properties in an effort to transform their current spaces into their dream homes. This shift in mindset is drive by a variety of factors, from financial considerations to environmental concerns and the desire for more personalised living spaces.   [A room with a table and chairs Description automatically generated]   Below, property expert Thomas Goodman at MyJobQuote.co.uk  goes

Leqembi[®] launched in South Korea

Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi[®] (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer’s disease (AD) or mild AD dementia (early AD).Eisai estimates there were approximately 900,000 dementia patients in South Korea in 2021, with one in ten people over the age of 65 suffering from dementia, and one in five from mild cognitive impairment (MCI). It is

Dooba Finance AB (publ) issues subsequent bonds of SEK 100 million

Dooba Finance AB (publ) (the “Company”) has successfully issued senior unsecured bonds in the amount of SEK 100,000,000 under the Company’s existing framework of up to SEK 800,000,000 senior unsecured guaranteed sustainability-linked floating rate bonds due 2027 (ISIN: NO0013219493) at an issue price of 100 per cent (the “Subsequent Bonds” or the “Subsequent Bond Issue”). The total outstanding nominal amount after the Subsequent Bond Issue will be SEK 800,000,000. The Company is intending to use the net proceeds from the Subsequent Bond Issue to finance general corporate purposes including

Request for an Extraordinary General Meeting in Kongsberg Automotive

Kongsberg, November 27, 2024: A group of shareholders represented by Arne Fredly and Arild Christoffersen, constituting 17.2% of the votes in Kongsberg Automotive ASA (KA), has requested that an Extraordinary General Meeting is summoned for election of new members of KA's Board of Directors and election of new members of KA`s Nomination Committee. The group of shareholders have proposed that Olav Volldal and Bård Klungseth are elected as new members of KA's Board of Directors, and that these candidates upon their election replace current members Peter Thostrup (chair) and Erik Volden.

Nordea Bank Abp: Repurchase of own shares on 27.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares27.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |144,871|10.52 |1,524,289.

Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million

Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EETTHE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Bioretec Ltd ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, hereby announces the result of the offering of new shares (the "Placing Shares") in a private placement to institutional and other qualified investors (

Spermosens publishes outcome in rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE   On 3 October 2024, Spermosens AB (publ) (“Spermosens” or the “Company”) announced a rights issue of units of approximately SEK 22.7 million (the “Rights Issue”). The subscription period of the Rights Issue ended on 25

Panoro Energy ASA – Successful Placement of USD 150 Million Senior Secured Bond

Oslo, 27 November 2024 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to announce that it has successfully completed a 5-year senior secured bond issue of USD 150 million with a coupon rate of 10.25 per cent.  The bonds will be issued at 99.20 per cent of nominal value. The bond issue attracted strong interest from both international and Nordic investors and was significantly oversubscribed. The net proceeds from the bond issue shall be applied towards refinancing of existing debt and general corporate purposes. Settlement of the bond issue is expected on or about 11 December

Gentoo Media - Mandatory notification of trade

MJ Foundation Fundacja Rodzinna, a company related to Mateusz Juroszek, Board Member and primary insider of Gentoo Media Inc. (Gentoo) has today acquired 129 shares in Gentoo at a price of SEK 24.30 per share. After this transaction, close associates of Mateusz Juroszek hold 24,163,445 shares in Gentoo. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. About Gentoo Media Gentoo Media is a market-leading affiliate connecting operators and players in the online gambling and sports betting industry. Gentoo Media

There are no items matching the current filter
There are no more items matching the current filter
Back to top